Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.

ABSTRACT:

SUBMITTER: De Souza A 

PROVIDER: S-EPMC7604263 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature